Hillhurst Biopharmaceuticals, Inc.

About Hillhurst Biopharmaceuticals, Inc.

Hillhurst Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on unlocking the potential of therapeutic gases through novel liquid medicines. Their proprietary GLASS platform enables oral delivery of agents previously limited to inhaled methods, improving safety, convenience, and dosing accuracy for at-home administration. They are committed to addressing debilitating diseases with limited treatment options.

Products & Services

GLASS Platform:A proprietary technology that enables oral delivery of therapeutic gases as liquid medicines, enhancing safety, convenience, and accuracy for at-home use.

Pipeline Candidates:Novel liquid therapeutic candidates targeting sickle cell disease, Parkinson's disease, diabetic retinopathy, and acute pain.

HBI-201:A therapeutic under development for pain management.

Specialties

Therapeutic Gases Oral Liquid Delivery Systems Sickle Cell Disease Treatment Parkinson's Disease Treatment Diabetic Retinopathy Treatment Pain Management

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 6300000 MR: - FA: $6.3 million FAN: 6300000	D: 2025-05-08 FD: 2025-05-08	2 investors
2	RT: SBIR Grant T: - FT: SBIR Grant	A: 3000000 MR: - FA: approximately $3 million FAN: 3000000	D: 2023-09-20 FD: 2023-09-20	1 investors

Grant Latest

2025-05-08

$6.3M

2 investors (Pro only)

SBIR Grant 2023-09-20

$3.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Celi Richardson

E

Edward Gomperts

Founder and Chairman

A

Andrew Gomperts

President and Chief Executive Officer

A

Alison Arter

Chief Commercial Officer

K

Kevin Bracken

Senior Chemistry, Manufacturing, and Controls Advisor

B

Bonnie Mills

Vice President, Regulatory and Clinical Operations

View 6 more team members with Pro

Unlock Full Team Directory

Recent News